Provider of medical communications and commercialization services for biopharma specializing in rare disease
Sector
Pharma Services
Status
Active
CEO
John Ribble
President
Investment Year
2025
John Ribble
CEO and Co-Chairman,
CEO,
MedComms Experts
President and Co-Chairman,
MedComms Experts
